|
   |
|
LETTER TO EDITOR |
|
|
|
| Year : 2018 | Volume
: 34
| Issue : 3 | Page : 235-236 |
| |
Change in the ranking and increasing trend of the prostate cancer from the population-based cancer registries in India
Atul Budukh, Ganesh Bakshi, Gagan Prakash
Tata Memorial Centre, Mumbai, Maharashtra, India
| Date of Submission | 09-Apr-2018 |
| Date of Acceptance | 06-Jun-2018 |
| Date of Web Publication | 29-Jun-2018 |
Correspondence Address:
Atul Budukh
Tata Memorial Centre, Mumbai, Maharashtra
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/iju.IJU_112_18
How to cite this article:
Budukh A, Bakshi G, Prakash G. Change in the ranking and increasing trend of the prostate cancer from the population-based cancer registries in India. Indian J Urol 2018;34:235-6 |
How to cite this URL:
Budukh A, Bakshi G, Prakash G. Change in the ranking and increasing trend of the prostate cancer from the population-based cancer registries in India. Indian J Urol [serial online] 2018 [cited 2023 Mar 25];34:235-6. Available from: https://www.indianjurol.com/text.asp?2018/34/3/235/235525 |
Dear Editor,
Globally, prostate cancer is the second most frequently diagnosed cancer and the fifth most common cause of cancer death among men with an estimated 1.1 million new cases (15% of all cancer in men) and 0.3 million cancer deaths (7% of all cancer deaths) in men in 2012.[1] In India, there were 19,095 incidences and 12,231 death cases in 2012.[2] The population-based cancer incidence data from cancer registries in the five continents is regularly published by the International Agency for Research on Cancer, Lyon, France (CI5).[3] We evaluated data from the Mumbai, Chennai, Barshi, and Bengaluru registries, published in the CI5, to determine the ranking of prostate cancer in the period of 1988–1992 and in the recent data of the year 2008–2012.[3],[4]
In the period of 1988–1992, prostate cancer age-adjusted incidence rate was reported as 7.9, 3.6, 1.4, and 4.7 per 100,000 and the rank among the leading cancer site was at number 5, 10, 11, and 6, respectively, in Mumbai, Chennai, Barshi, and Bengaluru registries. There was a shift in the ranking of the prostate cancer from number 5 to 2, 10 to 6, 11 to 9, and 6 to 3 in these registries in the period of 2008–2012. There is an increasing trend in the incidence rate of prostate cancer in the age group of ≥65 years. The incidence rate for the age group of ≥65 years in the period of 1988–1992 was 92.0, 38.8, 9.2, and 49.0 per 100,000, respectively, in Mumbai, Chennai, Barshi, and Bengaluru registries; however, in the period of 2008–2012, it was 100.3, 69.7, 20.8, and 92.1, respectively. The detail of this data is presented in [Table 1]. | Table 1: Prostate cancer incidence rate and leading cancer site rank in the period of 1988-1992 and 2008-2012 from Mumbai, Chennai, Barshi, and Bengaluru population-based cancer registries
Click here to view |
There was a change in the incidence rate of age group of ≥65 years by 11.9%, 80%, 126.1%, and 88%, respectively, in Mumbai, Chennai, Barshi, and Bengaluru registries in the period of 2008–2012 as compared to the period of 1988–1992. As per the recent report published by the National Cancer Registry Programme, an increasing trend in the prostate cancer in Mumbai, Chennai, Delhi, Bhopal, and Bengaluru registries has been reported.[5]
Most of the prostate cancer cases get diagnosed at the age of ≥65 years. The change in the ranking of the prostate cancer is due to the increase in the older population and improvement in the diagnosis. For the prevention of prostate cancer, it would be prudent to explore the possibility of early detection to prevent the complications due to disease. We have to focus on the population which is likely to suffer from such complications with good life expectancy. The risk factor for the disease which can be used as a public health intervention tool for prostate cancer prevention needs to be explored using well-designed large-scale population-based study.
Financial support and sponsorship:
Nil.
Conflicts of interest:
There are no conflicts of interest.
 References | |  |
| 1. | Humphrey PA. Cancers of the male reproductive organs. In: Stewart BW, Wild CP, editors. World Cancer Report 2014. Lyon, France: A Publication of International Agency for Research on Cancer; 2014. p. 453-64.  |
| 2. | Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11. Available from: http://www.globocan.iarc.fr/Default.aspx. [Downloaded on 2018 Apr 02]. |
| 3. | Cancer Incidence in Five Continents. Vol. 1-10. Lyon, France: Publication of International Agency for Research on Cancer, International Association of Cancer Registries. Available from: http://www.ci5.iarc.fr/CI5I-X/Default.aspx. [Downloaded on 2018 Apr 02]. |
| 4. | Bray F, Colombet M, Mery L, Piñeros M, Znaor A, Zanetti R, et al., editors. Cancer Incidence in Five Continents. (Electronic Version) Vol. 11 th. Lyon: International Agency for Research on Cancer; 2017. Available from: http://www.ci5.iarc.fr. [Last accessed on 2018 Apr 05]. |
| 5. | National Cancer Registry Programme. Three Year Report of Population Based Cancer Registries 2012-2014. Bengaluru, India: Indian Council of Medical Research; 2016. |
[Table 1]
|
